-+ 0.00%
-+ 0.00%
-+ 0.00%

THE NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES RESULTS FROM PHASE 1/2 MARINA® TRIAL OF DELPACIBART ETEDESIRAN (DEL-DESIRAN) FOR TREATMENT OF MYOTONIC DYSTROPHY TYPE 1

Reuters·02/18/2026 22:00:02

Please log in to view news